Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Venmax Drugs
Venmax Drugs
BSE: 531015NSE: ISIN: INE154G01022

21st-Jan-2020 15:23Source: BSE

Venmax Drugs and Pharmaceuticals - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Raj Kumar Rai
Designation :- Managing Director / Whole Time Director

Sections
Follow us on